Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methylprednisolone added to standard treatment for COVID-19 pneumonia
2020-004323-16Phase 2Completed
- Sponsor
- Santa Maria Nuova
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylprednisolone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Santa Maria Nuova. Primary endpoint: Length of hospitalization. Started Nov 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-004323-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004323-16.